Trial
NCT01709734
A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
LTN PHARMACEUTICALS, INC.
Collaborators
—
Condition
Prostate Cancer
Intervention
galeterone
Why stopped
Study was terminated prematurely in all investigational study centers upon recommendation from the study's Data Monitoring Committee (DMC).
Study was stopped due to lack of efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-15